Mehmet Ilker Gokce

Mehmet Ilker Gokce

Auto-generated profile, based on publicly available information

Mehmet Ilker Gokce

Department of Urology, Faculty of Medicine, Ankara University, Ankara, Türkiye

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2015 in BJU International
Verified
Journal Article
Closed access
PDF file
SBSümer Baltacı
Sümer Baltacı
MBMurat Bozlu
Murat Bozlu
AYAsıf Yıldırım
Asıf Yıldırım
MGMehmet Ilker Gökçe
Mehmet Ilker Gökçe
ITIlker Tinay
Ilker Tinay
AMAydın Mungan
Aydın Mungan

1 February 2015 in International braz j urol
Verified
Journal Article
Open access
PDF file
MGMehmet Ilker Gokce
Mehmet Ilker Gokce
EOEriz Ozden
Eriz Ozden
ESEvren Suer
Evren Suer
BGBasak Gulpinar
Basak Gulpinar
OGOmer Gulpınar
Omer Gulpınar
STSemih Tangal
Semih Tangal
Key words: Urolithiasis; Kidney Calculi; Ultrasonography; Tomography, X-Ray Computed

8 May 2017 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
ÖGÖmer Gülpınar
Ömer Gülpınar
BEBarış Esen
Barış Esen
AKAytaç Kayış
Aytaç Kayış
MGMehmet Ilker Gökçe
Mehmet Ilker Gökçe
ESEvren Süer
Evren Süer

4 November 2015 in Canadian Urological Association Journal
Verified
Journal Article
Open access
PDF file
MGMehmet Ilker Gokce
Mehmet Ilker Gokce
NHNurullah Hamidi
Nurullah Hamidi
ESEvren Suer
Evren Suer
STSemih Tangal
Semih Tangal
AHAdil Huseynov
Adil Huseynov
AIArif Ibiş
Arif Ibiş
Introduction: We evaluate the role of NLR prior to prostate biopsy to predict biopsy histology and Gleason score in patients with prostate cancer.Methods: In this retrospective study, we evaluated data of patients underwent prostate biopsy between May 2005 and March 2015. We collected the following data: age, prostate-specific antigen (PSA), biopsy histology, Gleason score (GS) in prostate cancer patients, neutrophil counts, and lymphocyte counts. Patients were grouped as benign prostatic hyperplasia (BPH), prostate cancer, and prostatitis. The Chi square test was used to compare categorical variables and analysis of variance (ANOVA) was applied for continuous variables.Results: Data of 1836 patients were investigated. The mean age, total PSA and neutrophil-lymphocyte ratio (NLR) of the population were 66.8 ± 8.17 years, 9.38 ± 4.7 ng/dL, and 3.11 ± 1.71, respectively. Patients were divided as follows: 625 in the group with BPH history, 600 in the prostatitis group, and 611 in the prostate cancer histology group. The mean NLR of the prostatitis group was higher compared to the prostate cancer and BPH groups (p = 0.0001). The mean NLR of the prostate cancer group was significantly higher compared to the BPH group (p = 0.002). The GS 8–10 group had a significantly higher mean NLR compared to GS 5–6 (3.64 vs. 2.54, p = 0.0001) and GS 7 (3.64 vs. 2.58, p = 0.0001) patients.Conclusions: NLR was found to differ with regard to histology of prostate biopsy and higher GS was associated with higher NLR in patients with prostate cancer. However prostatitis prevents the use of NLR in predicting prostate cancer before a prostate biopsy. Also, the retrospective nature and lack of multivariate analysis in this study somewhat limits the relevance of these results.

1 August 2014 in Journal of Urology
Verified
Journal Article
Closed access
MGMehmet İlKer Gökçe
Mehmet İlKer Gökçe
PHParviz Hajıyev
Parviz Hajıyev
ESEvren Süer
Evren Süer
YKYusuf Kibar
Yusuf Kibar
MSMesrur Selçuk Sılay
Mesrur Selçuk Sılay
BBBerk Burgu
Berk Burgu
Relapse after cessation of desmopressin is an important problem in treating patients with enuresis. Structured withdrawal of desmopressin tablets has been shown to decrease relapse rates. However, scientific data are lacking on the structured withdrawal of the fast melting oral formulation of desmopressin. We compared relapse rates of structured withdrawal using placebo and direct cessation in a population of patients with enuresis who were desmopressin responders. Patients diagnosed with enuresis and responding to desmopressin from 13 different centers were involved in the study. Patients were randomized into 4 groups. Two different structured withdrawal strategies were compared to placebo and direct withdrawal. Sample size was estimated as 240 (60 patients in each group), with a power of 0.80 and an effect size of 30%. Randomization was performed using NCSS statistical software (NCSS, Kaysville, Utah) from a single center. The relapse rates of the groups were compared using chi-square testing. Logistic regression analysis was performed to define the independent factors having an effect on relapse rates. Desmopressin treatment was initiated in 421 patients, and 259 patients were eligible for randomization. Relapse rates were 39 (1%) and 42 (4%) for the structured withdrawal groups, which were significantly less than for direct withdrawal (55, 3%) and placebo (53, 1%). Logistic regression analysis revealed that initial effective dose of 240 μcg, greater number of wet nights before treatment and nonstructured withdrawal were associated with higher relapse rates. We found that structured withdrawal with the fast melting oral formulation of desmopressin results in decreased relapse rates. Application of a structured withdrawal program was also an independent factor associated with reduced relapse rates, together with lower initial effective dose and number of wet nights per week. Relapse after cessation of desmopressin is an important problem, and in this study structured withdrawal was observed to be associated with decreased relapse rates compared to placebo and direct withdrawal.

1 June 2011 in International braz j urol
Verified
Journal Article
Open access
PDF file
OAOzgu Aydogdu
Ozgu Aydogdu
MGMehmet Ilker Gokce
Mehmet Ilker Gokce
BBBerk Burgu
Berk Burgu
SBSumer Baltaci
Sumer Baltaci
OYOnder Yaman
Onder Yaman
To evaluate the change in penile size r bilateral nerve sparing retropubic radical prostatectomy (BNSRRP) and possible effect of Tadalafil. A total of 65 patients underwent BNSRRP and they were evaluated prospectively for a whole year of follow-up. The patients were randomized to control without rehabilitation (Group 1) or Tadalafil rehabilitation group (Group 2). The patients were evaluated at months 3, 6 and 12 postoperatively for erectile function, penile measurements (flaccid penile length, penile length at maximum erection, penile circumference at flaccid status, and penile circumference at maximum erection), penile abnormalities and general health status. Statistical analysis was performed by Chi-Square test and significance was defined as p value < 0.05. In Group 1 there was significant decrease in penile measurements at month 3 compared to preoperative measurements. There was decrease in all parameters at month 6 compared to month 3 but only the decrease in penile length at maximum erection was significant. There were no significant differences between postoperative months 6 and 12 for all measurements. In Group 2 there was a tendency to decrease in all measurements at month 3 compared to baseline. There was no significant difference for penile measurements between postoperative 3rd and 6th months and between 6th month and the first year. Although further large sampled trials are needed to describe the possible positive effect of tadalafil or other PDE5-I 's on penile size after BNSRRP, tadalafil rehabilitation is effective in preserving penile size especially in the early postoperative period after BNSRRP.